An adverse reaction of an anticancer drug is a harmful and an unintended reaction by patient suffering from cancer disease who is often polymedicated. The treatment of cancers by anti-cancer molecules produces serious adverse drug effects. The main purpose of this paper is to present and evaluate the digestive adverse effects involved in anti-cancer drugs and their potential of correlation to anticipate, prevent and improve the quality of care of patient suffering from cancer disease. This is a prospective study that that enrolled 147 patients seen between January 25 and June 25, 2009 with adverse drug reactions due to an anticancer treatment. Breast and cavum cancers present 34% of cases. The average age was 46.52 years. The sex ratio (M / F) was 0.33. During the study period 283 Adverse drug effects of anticancer drugs were collected with a predominance (132) adverse digestive effects and 32 anticancer drugs European Scientific Journal November 2016 edition vol.12, No.33 ISSN: 1857 -7881 (Print) e -ISSN 1857 455 were counted on all medical prescriptions. Nausea and vomiting are the most common side effects, sometimes very severe. The availability of anti-emetics in the family of 5-HT3 serotoninergic antagonists has considerably improved the experience of patients undergoing anticancer chemotherapy, hence the importance of pharmacovigilance as a tool is to improve the quality of anticancer care.Keywords: Digestive adverse effects, anticancer drugs, Chemotherapy, Cancers, supported.
RésuméUn Mots clés : Effets indésirables digestifs, anticancéreux, Chimiothérapie, Cancers, prise en charge.
IntroductionLa sĂ©curitĂ© d'emploi des mĂ©dicaments anticancĂ©reux reprĂ©sente un des grands problĂšmes contemporains de la santĂ© publique, d'oĂč la nĂ©cessite d'un suivi trĂšs rigoureux par la pharmacovigilance. De nombreuses Ă©tudes ont dĂ©montrĂ© que la toxicitĂ© liĂ©e Ă l'utilisation des mĂ©dicaments en gĂ©nĂ©rale reprĂ©sentait un problĂšme majeur dont les professionnels de santĂ© et les